Preparation of Nano-Medicine to Eliminate Helicobacter pylori Infection

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 40

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ARCHRAZI-78-4_017

تاریخ نمایه سازی: 6 دی 1402

چکیده مقاله:

Helicobacter pylori (H. pylori) is considered a challenging type of bacteria that is difficult to treat with the currently used antibiotics, such as amoxicillin, erythromycin, and metronidazole, which have proven ineffective against these bacteria. In this study, modern technology was used to treat these bacteria by converting the aforementioned antibiotics to their nano state using the lyophilization method and diagnosing them using scanning electron microscopy. A mixture of the three nano-antibiotics was prepared in the form of a nano-medicine, which was used to treat H. pylori bacteria in cultures and determine the effectiveness of nano-antibiotics and nano-medicine on these bacteria. The findings showed that nano-medicine was highly effective in inhibiting these bacteria at the lowest concentration (OD=۰.۰۴۲) and the highest concentration (OD=۰.۰۳۸), compared to the three micro-antibiotics individually. The OD values ​​of amoxicillin, azithromycin, and metronidazole were ۰.۵۲۳, ۰.۵۲۱, and ۰.۴۵۳, respectively. The OD values ​​of the three nano-antibiotics, including nano-amoxicillin, nano-azithromycin, and nano-metronidazole, were ۰.۳۸۶, ۰.۲۵۸, and ۰.۱۶۷, respectively. It was observed that the percentage of inhibition in each of the nano-antibiotics was higher than the inhibition in micro-antibiotics and that the nano-medicine had much higher inhibition than each of the three micro- and nano-antibiotics alike. The safety of using nano-antibiotics in the prepared medicine was confirmed using electrochemical technology and cyclic voltammetry to identify the electrochemical properties through oxidation and reduction in blood media. Based on the findings, only reduction peaks appeared, and there were no oxidation peaks in the prepared kit or for each of the three nano-antibiotics. It was found that they were all non-oxidants and could be used safely as good antioxidants in treatments. However, the same three micro treatments showed blood oxidation due to the appearance of oxidation peaks in all of them. The study proved that all H. pylori isolates are resistant to usable antibiotics. All of the antibiotics in the nano-medicine had an anti-bacterial effect, and the effect of the new form of antibiotic was proportional to the concentration of the antibiotic.

نویسندگان

S Abbas Hussein Al-Saeed

Laboratory Techniques Department, College of Health and Medical Techniques, Middle Technical University (MTU), Baghdad, Iraq

M Mizher Radhi

Radiological Techniques Department, College of Health and Medical Techniques, Middle Technical University (MTU), Baghdad, Iraq

Z Numan Hamed

Laboratory Techniques Department, College of Health and Medical Techniques, Middle Technical University (MTU), Baghdad, Iraq

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Luigi S. Helicobacter pylori infection. ۲۰۲۱ ...
  • Grande R, Sisto F, Puca V, Carradori S, Ronci M, ...
  • Cardos IA, Zaha DC, Sindhu RK, Cavalu S. Revisiting Therapeutic ...
  • Alsaiari NS, Katubi KMM, Alzahrani FM, Siddeeg SM, Tahoon MA. ...
  • Fateh R, Javadi A, Kardan-Yamch J, Ali Rahdar H, Amini ...
  • Wu T, Wang L, Gong M, Lin Y, Xu Y, ...
  • Silva FM, Eisig JN, Teixeira AC, Barbuti RC, Navarro-Rodriguez T, ...
  • Silva FM, Eisig JN, Chehter EZ, da Silva JJ, Laudanna ...
  • Hirsch FG, Texter EC, Jr., Wood LA, Ballard WC, Jr., ...
  • Hrioua A, Loudiki A, Farahi A, Bakasse M, Lahrich S, ...
  • Fouladgar M, Hadjmohammadi MR, Khalilzadeh MA, Biparva P, Teymoori N, ...
  • نمایش کامل مراجع